Phosphonate inhibitors of HCV
US7842672B2 · kind B2 · utility
93Cited by
7References
107Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2007 |
| Grant date | Nov 30, 2010 |
| Priority date | — |
| Expiry date | Apr 5, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of Formula I, Formula II, Formula III, or Formula IV:or a pharmaceutically acceptable salt, solvate, and/or ester thereof, therapeutic compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.